5MHD image
Deposition Date 2016-11-24
Release Date 2017-08-09
Last Version Date 2024-11-13
Entry Detail
PDB ID:
5MHD
Keywords:
Title:
Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutions.
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
20
Selection Criteria:
20 structures for lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Mutations:22S
Chain IDs:A
Chain Length:22
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Insulin
Gene (Uniprot):INS
Chain IDs:B
Chain Length:31
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structure and pharmaceutical formulation development of a new long-acting recombinant human insulin analog studied by NMR and MS.
J Pharm Biomed Anal 135 126 132 (2017)
PMID: 28024260 DOI: 10.1016/j.jpba.2016.12.005

Abstact

A monomer structure of a novel human insulin analog A22S-B3K-B31R (SK3R) has been characterized by NMR in water/acetonitrile solution and compared with the structure of human insulin (HIS) established in the same medium. The composition of the oligomer ensemble for neat insulins in water was qualitatively assessed by monitoring, derived from NMR experiment, translational diffusion coefficient Dix10-10m2s-1, whose value is a population averaged of individual coefficients for species in oligomeric ensemble. Nanospray ESI/MS experiment was used to establish the masses of oligomers in pharmaceutical formulation of the SK3R insulin. The pharmacodynamic data were established and compared to insulin glargine characterized by the same profile of action in diabetics. The oligomerization process of insulin during development of pharmaceutical formulation with routinely used excipients has been studied using translation diffusion coefficient Dix10-10m2s-1 established in water solution. These properties were compared with those of human insulin (HIS) which is a standard reference for novel recombinant insulins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures